An error has occurred

Library | TayganPoint Consulting Group

Library

Including Quality Risk Management in Your Portfolio

Quality defects remain a significant cause of health authority inspection findings. According to the EMA Good Clinical Practice Inspectors Working Group, findings related to quality-related issues such as Protocol Design, Protocol Compliance, Monitoring, and Data Management accounted for 23% of all findings in 2012, 21% in 2013, and 21% in...

Read More

TayganPoint is Proud to be Re-Certified by WBENC as a Women Owned Business

TayganPoint Consulting Group was recently re-certified as a woman owned business by the Women’s Business Enterprise National Council (WBENC). This is the 9th successive year of affiliation for TayganPoint.  WBENC, founded in 1997, is the nation’s leading advocate of women-owned businesses as suppliers to America’s corporations. It is the largest third-party certifier of businesses...

Read More

Social Responsibility: Life Science Leadership’s Next Secret Weapon

Entering Merck soon after Ken Frazier stepped down from President Trump’s Manufacturing Council, I was struck with newfound feelings of trust, connection and pride. Walking the halls, I found hundreds of people, from all backgrounds, ethnicities, ages enroute to contribute to Merck, it’s vision, and its mission. With recent events...

Read More

Fall Forum Recap: Adventures in Supply Chain Innovation

Improving Supply Chain Management has rapidly risen to the top of the enterprise agenda – with innovation at the core of the discussion.  But what does Supply Chain Innovation mean? What does it take to succeed? And how do innovative supply chains develop and sustain? In December, TayganPoint hosted its...

Read More

The Do’s and Don’ts of Business Transformation

On Oct. 12 Healthcare Businesswomen’s Association hosted a panel exploring the successes and failures of business transformation in life sciences. The panelists, who have all thankfully lived to tell the tale, shared their transformation do’s and don’ts based on pitfalls and successes of their endeavors. Transformation truly touches every level of...

Read More

Managing a Portfolio of Drug Development Projects: How to Find More Certainty in an Uncertain World

The drug development business is fraught with uncertainty.  Unpredictability in discovering and testing new molecular compounds or biologics – ranging from the scientific, operational, financial, regulatory, and organizational – are inherent parts of the process. This article is not about forever-eliminating uncertainty in the drug development process; that will never...

Read More

The Great Social Media Challenge

One of our primary goals as an organization is providing our clients and friends unique insight on emerging industry trends as well as actionable ways to enact sustainable change within their company. With this in mind, we’d like to make it even easier to stay in touch and continue the conversation...

Read More

Joy Taylor Wins AWE’s 2017 Iris Newman Award

Joy Taylor Recognized as Shining Example of a Woman High-Growth Founder Sep 5, 2017 | Katie Burkhart Joy Taylor, Co-Founder and CEO of Tayganpoint Consulting Group, will receive the prestigious Iris Newman Award at The Intersection, which is presented by the Alliance of Women Entrepreneurs (AWE). AWE is the Greater Philadelphia...

Read More

TayganPoint Named to Philadelphia Business Journal’s List of Top Women-Owned Businesses in the Region

PRESS RELEASE FOR IMMEDIATE RELEASE CONTACT: Jennifer Compton  |  J&L Communications Jennifer@jandlcomms.com @jandlcomms  |  615-969-4737 Washington Crossing, PA  –  September 22, 2017  –  TayganPoint Consulting Group, a management consulting firm specializing in business transformation within pharma and the life sciences, has been named to the Philadelphia Business Journal’s Top Women-Owned...

Read More

The Role of Technology and Innovation in Healthcare: Driving Business Success

Vitalized by technology-driven advances, yet constrained by complexity, healthcare and the ecosystem of the healthcare industry – pharma, biotech, providers, payers, government – is also changing at an accelerated rate. Regulatory and reporting requirements, patient-centricity expectations, and socio-demographic factors are bringing supply chain, R&D, and sales and marketing challenges to...

Read More

Archives